Avista Healthcare Public Acquisition

Avista Healthcare Public Acquisition Overview

Founded 2015
Founded
Status Acquired/​Merged
Employees 4
Employees
Latest Deal Type M&A
Financing Rounds 3

Avista Healthcare Public Acquisition General Information

Description

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Holding Companies
Acquirer
Primary Office
  • 65 East 55th Street
  • 18th Floor
  • New York, NY 10022
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avista Healthcare Public Acquisition Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avista Healthcare Public Acquisition‘s full profile, request access.

Request a free trial

Avista Healthcare Public Acquisition Executive Team (1)

Name Title Board Seat Contact Info
David Burgstahler President & Chief Executive Officer